ILMN
Price
$136.02
Change
+$2.02 (+1.51%)
Updated
Dec 20 closing price
45 days until earnings call
MYGN
Price
$13.36
Change
+$0.19 (+1.44%)
Updated
Dec 20 closing price
71 days until earnings call
Ad is loading...

ILMN vs MYGN

Header iconILMN vs MYGN Comparison
Open Charts ILMN vs MYGNBanner chart's image
Illumina
Price$136.02
Change+$2.02 (+1.51%)
Volume$14.35M
CapitalizationN/A
Myriad Genetics
Price$13.36
Change+$0.19 (+1.44%)
Volume$3.97M
CapitalizationN/A
ILMN vs MYGN Comparison Chart
Loading...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ILMN vs. MYGN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ILMN is a Hold and MYGN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ILMN: $136.02 vs. MYGN: $13.36)
Brand notoriety: ILMN: Notable vs. MYGN: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ILMN: 662% vs. MYGN: 395%
Market capitalization -- ILMN: $21.09B vs. MYGN: $1.93B
ILMN [@Medical Specialties] is valued at $21.09B. MYGN’s [@Medical Specialties] market capitalization is $1.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ILMN’s FA Score shows that 0 FA rating(s) are green whileMYGN’s FA Score has 1 green FA rating(s).

  • ILMN’s FA Score: 0 green, 5 red.
  • MYGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ILMN and MYGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ILMN’s TA Score shows that 3 TA indicator(s) are bullish while MYGN’s TA Score has 2 bullish TA indicator(s).

  • ILMN’s TA Score: 3 bullish, 5 bearish.
  • MYGN’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both ILMN and MYGN are a bad buy in the short-term.

Price Growth

ILMN (@Medical Specialties) experienced а -5.46% price change this week, while MYGN (@Medical Specialties) price change was -7.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +2.97%.

Reported Earning Dates

ILMN is expected to report earnings on Feb 06, 2025.

MYGN is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ILMN($21.1B) has a higher market cap than MYGN($1.93B). ILMN YTD gains are higher at: 0.499 vs. MYGN (-30.199). MYGN has higher annual earnings (EBITDA): -197.4M vs. ILMN (-608M). ILMN has more cash in the bank: 1.05B vs. MYGN (141M). MYGN has less debt than ILMN: MYGN (152M) vs ILMN (2.26B). ILMN has higher revenues than MYGN: ILMN (4.5B) vs MYGN (753M).
ILMNMYGNILMN / MYGN
Capitalization21.1B1.93B1,095%
EBITDA-608M-197.4M308%
Gain YTD0.499-30.199-2%
P/E Ratio49.50N/A-
Revenue4.5B753M598%
Total Cash1.05B141M748%
Total Debt2.26B152M1,488%
FUNDAMENTALS RATINGS
ILMN vs MYGN: Fundamental Ratings
ILMN
MYGN
OUTLOOK RATING
1..100
8760
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
4691
P/E GROWTH RATING
1..100
941
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ILMN's Valuation (76) in the Biotechnology industry is in the same range as MYGN (95). This means that ILMN’s stock grew similarly to MYGN’s over the last 12 months.

ILMN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MYGN (100). This means that ILMN’s stock grew similarly to MYGN’s over the last 12 months.

ILMN's SMR Rating (95) in the Biotechnology industry is in the same range as MYGN (97). This means that ILMN’s stock grew similarly to MYGN’s over the last 12 months.

ILMN's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for MYGN (91). This means that ILMN’s stock grew somewhat faster than MYGN’s over the last 12 months.

MYGN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ILMN (94). This means that MYGN’s stock grew significantly faster than ILMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ILMNMYGN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X95104.940000-2119.789000
-2.18%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+1.51%
RVTY - ILMN
54%
Loosely correlated
+1.83%
A - ILMN
46%
Loosely correlated
+0.99%
BNGO - ILMN
45%
Loosely correlated
-2.74%
TMO - ILMN
44%
Loosely correlated
+1.42%
AZTA - ILMN
41%
Loosely correlated
+1.88%
More

MYGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with TMO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
+1.44%
TMO - MYGN
39%
Loosely correlated
+1.42%
WAT - MYGN
39%
Loosely correlated
+2.09%
GMED - MYGN
37%
Loosely correlated
+0.84%
VCYT - MYGN
36%
Loosely correlated
+4.66%
ILMN - MYGN
35%
Loosely correlated
+1.51%
More